Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000378:metabolism; D002845:Chromatography; D011756:Diphosphates / Q000378:metabolism; D004357:Drug Synergism; D008223:Lymphoma / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D015122:Mercaptopurine / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D009705:Nucleosides / Q000627:therapeutic use*; D009711:Nucleotides / Q000378:metabolism; D010428:Pentosephosphates / Q000378:metabolism; D012266:Ribose / Q000378:metabolism / Q000627:therapeutic use
D000963:Antimetabolites; D002247:Carbon Isotopes; D011756:Diphosphates; D009705:Nucleosides; D009711:Nucleotides; D010428:Pentosephosphates; D012266:Ribose; D015122:Mercaptopurine